Initial Experience With Nifekalant Hydrochloride (MS-551), A Novel Class III Antiarrhythmic Agent, in Patients With Acute Extensive Infarction and Severe Ventricular Dysfunction
-
- Takenaka Kotoe
- Division of Cardiology, Department of Medicine, National Cardiovascular Center
-
- Yasuda Satoshi
- Division of Cardiology, Department of Medicine, National Cardiovascular Center
-
- Miyazaki Shunichi
- Division of Cardiology, Department of Medicine, National Cardiovascular Center
-
- Kurita Takashi
- Division of Cardiology, Department of Medicine, National Cardiovascular Center
-
- Sutani Yasuo
- Division of Cardiology, Department of Medicine, National Cardiovascular Center
-
- Morii Isao
- Division of Cardiology, Department of Medicine, National Cardiovascular Center
-
- Daikoku Satoshi
- Division of Cardiology, Department of Medicine, National Cardiovascular Center
-
- Kamakura Shiro
- Division of Cardiology, Department of Medicine, National Cardiovascular Center
-
- Nonogi Hiroshi
- Division of Cardiology, Department of Medicine, National Cardiovascular Center
この論文をさがす
抄録
Nifekalant hydrocholoride, a novel class III antiarrhythmic agent, was used as the treatment in 4 patients with extensive anterior infarction and severe ventricular dysfunction. The malignant ventricular tachyarrhythmia was effectively suppressed at a relatively low dose, without compromising the hemodynamics, indicating that this potent K+ channel blocker has therapeutic potential for acute myocardial infarction. (Jpn Circ J 2001; 65: 60 - 62)
収録刊行物
-
- JAPANESE CIRCULATION JOURNAL
-
JAPANESE CIRCULATION JOURNAL 65 (1), 60-62, 2001
社団法人 日本循環器学会
- Tweet
詳細情報
-
- CRID
- 1390001206432668032
-
- NII論文ID
- 110002635349
-
- NII書誌ID
- AA00690731
-
- COI
- 1:CAS:528:DC%2BD3MXktFShsg%3D%3D
-
- ISSN
- 13474839
- 00471828
- http://id.crossref.org/issn/00471828
-
- PubMed
- 11153825
-
- 本文言語コード
- en
-
- データソース種別
-
- JaLC
- Crossref
- PubMed
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可